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Abstract: Cyanobacterial harmful algal blooms represent one of the most conspicuous 
waterborne microbial hazards in aquatic environments mostly due to the production of toxic 
secondary metabolites, mainly microcystins (MCs). Other bioactive peptides are frequently 
found in cyanobacterial blooms, yet their concentration and ecological relevance is still 
unknown. In this paper we studied the presence and concentration of cyanobacterial peptides 
(microcystins, anabaenopeptins, anabaenopeptilides) in 36 Greek freshwater bodies, using  
HPLC-DAD, ELISA, and PP1IA. Microcystins were found in more than 90% of the samples 
investigated, indicating that microcystin-producing strains seem to also occur in lakes 
without blooms. Microcystins MC-RR, MC-LR, and MC-YR were the main toxin 
constituents of the bloom samples. Anabaenopeptin A and B were predominant in some 
samples, whereas anabaenopeptolide 90A was the only peptide found in Lake Mikri Prespa. 
The intracellular concentrations of anabaenopeptins produced by cyanobacterial bloom 
populations are determined for the first time in this study; the high (>1000 µg·L−1) 
anabaenopeptin concentration found indicates there may be some impacts, at least on the 
ecology and the food web structure of the aquatic ecosystems. The maximum intracellular 
MC values measured in Lakes Kastoria and Pamvotis, exceeding 10,000 µg·L−1, are among 
the highest reported. 
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1. Introduction 
Cyanobacterial Harmful Algal Blooms (or CyanoHABs) represent one of the most conspicuous 
waterborne microbial hazards to human and agricultural water supplies, fisheries production, and 
freshwater and marine ecosystems [1]. This hazard results from the production of cyanotoxins, harmful 
secondary metabolites such as microcystins (MCs), saxitoxins, and cylindrospermopsins that can have 
deleterious effects within reservoirs and in downstream receiving water systems during releases [2]. The 
most frequent cyanotoxins in freshwater CyanoHABs are MCs, cyanobacterial heptapeptide 
hepatotoxins produced by cyanobacterial species belonging to Microcystis, Planktothrix, Anabaena 
(Dolichospermum), and Anabaenopsis (for a review see [2,3]). MCs are responsible for, by several 
exposure routes, a significant health hazard to livestock, wildlife, birds, fishes, and even humans [4], 
leading the World Health Organization (WHO) to propose implementation measures for monitoring and 
control of MCs and determine guideline values for drinking [5] and recreational [6] waters. 
During the past 20 years, many other bioactive peptide groups have been discovered in cyanobacteria, 
such as aeruginosins, microginins, cyanopeptolins, anabaenopeptins, anabaenopeptilides, microviridins, 
and nostophycins; to date, more than 600 cyanobacterial peptides have been described (for a review,  
see [7]). The continuous and rising interest stems both from the surveillance of aquatic systems, 
especially where toxic compounds are raising concerns of public health, and from various and diverse 
bioactivities of unique structures with potential pharmacological implications [7]. These peptides are 
frequently found in cyanobacterial blooms, along with numerous other not-yet-identified peptides [8–10]. 
Anabaenopeptins are unique cyclic peptides that have the common cyclic peptide moiety linked with 
Tyr, Arg, Lys, and Phe, via a ureido bond [11,12]. Anabaenopeptilides are 19-membered cyclic depsipeptides 
containing a unique residue, 3-amino-6-hydroxy-2-piperidone (Ahp) bond [11,12]. These peptides 
exhibit diverse bioactivities such as serine, trypsin, or chymotrypsin protease inhibition [7,10]. A better 
understanding of the production and toxicity of these peptides is essential to assess the environmental 
controls on peptide production and to guide cyanotoxin risk assessment [13]. Analyses of several toxic 
and non-toxic strains of cyanobacteria have shown that cyanobacteria may produce MCs and/or other 
peptides [13–15]. Therefore, a comprehensive understanding of the possible functions of bioactive 
peptides and their ecological impacts requires considering bioactive peptides as a group rather than 
focusing solely on MCs. 
The presence of MCs [16–19] and anabaenopeptins [16,20] has already been documented in 
Microcystis- and/or Anabaena (Dolichospermum)-dominated blooms, in Greece. The warm Mediterranean 
climate favors cyanobacteria blooms in eutrophic waters, which may start in spring and last until 
December [21], with MCs present throughout the year [17]. In this work we performed extensive 
sampling along many continental Greek lakes and reservoirs of different typology and trophic status, in 
order to further investigate the presence and concentration of cyanobacteria peptides (microcystins, 
anabaenopeptins, anabaenopeptilides) in the water and assess the possible risks posed. 
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2. Results 
2.1. Peptide Diversity 
Cyanobacteria blooms were found in 10 out of the 36 freshwater bodies surveyed (Figure 1). HPLC  
analysis of the water samples resulted in the identification of six different peaks in 41 out of 101 samples 
(HPLC-positive samples), which had the same retention time and UV absorption spectra as purified  
MC-LR, MC-RR, MC-YR, anabaenopeptin A, anabaenopeptin B, and anabaenopeptilide 90A, respectively. 
Peaks with retention times and corresponding fractions with UV spectra of [D-Asp3] MC-LR, [Dha7] 
MC-LR, MC-RR, [Dha7] MC-RR, [D-Asp3, Dha7] MC-LR, [D-Asp3] MC-RR, [D-Asp3, Dha7] MC-RR, 
and MC-LA were not found. Three additional peaks not corresponding to any of the available purified 
peptides were found. One peak had the same retention time and UV spectrum with MC U1 (see Section 4.2). 
The UV spectrum of the second peak indicated the presence of another unidentified MC, denoted U5. 
The UV spectrum of the third peak indicated the presence of a putative anabaenopeptin, denoted UA1. 
MC-RR and MC-LR were the predominant microcystins in 25 out of 41 HPLC-positive samples, with 
percentages of ΣMC ranging from 4% to 100% (mean 43%) and 2% to 100% (mean 56%), respectively 
(Figure 2a). MC-YR was also identified in eight samples with percentages of ΣMC ranging from 9% to 
31% (mean 14%), whereas the unidentified MC U1 was predominant in 17 out of 41 HPLC-positive 
samples with percentages of ΣMC ranging from 1% to 100% (mean 33%). MC U5 was predominant in 
two bloom samples with ΣMC percentages of 65% and 93% (Figure 2a). 
Anabaenopeptin B was predominant in three samples with percentages of ΣA ranging from 61% to 
100% (mean 77%), whereas anabaenopeptin A was predominant in one sample (Figure 3a). 
Anabaenopeptolide 90A was the only peptide found (Figure 3a) in one sample from Lake Mikri Prespa. 
The putative anabaenopeptin UA1 was the only anabaenopeptin found in 13 samples (Figure 3a) and the 
only peptide found in six out of 41 HPLC-positive samples. 
2.2. Peptide Concentrations and Occurrence Patterns 
Microcystins were found in 95% of the samples analyzed by HPLC, ELISA, and PP1IA, 
anabaenopeptins in 18.2% of the samples, and anabaenopeptilides in one sample (Table 1). Microcystins 
were found in 91% of the lakes sampled. The total intracellular microcystin concentration (ΣMC) 
measured in the water samples ranged from 0 to 13,230 µg·L−1 (Figure 2b). The MC-RR to MC-LR  
ratio ranged from 0.1 to 2.7 (mean 1.5) (Figure 2c). The sum of MC-LR and MC-RR percent relative 
concentration ranged from 70% to 100% (mean 83%), with the exception of two samples (Figure 2d). 
Total intracellular anabaenopeptin content (ΣA) ranged from undetectable to 1730 µg·L−1 (Figure 3b). 
ΣA constituted up to 100% of the total peptide content ΣP (Figure 3c). 
  
Mar. Drugs 2015, 13 6322 
 
 
 
Figure 1. Map of Greece showing the locations of the 36 water bodies (circles: natural lakes 
and reservoirs, rectangle: river, triangle: lagoon), examined for the occurrence of cyanobacterial 
peptides. Blue-green and light blue symbols indicate water bodies with or without blooms 
during sampling, respectively. The numbers 1 to 36 identify the water bodies: (1) Lake 
Vistonis; (2) Vasova Lagoon; (3) Lake Volvi; (4) Lake Koronia; (5) Kerkini Reservoir;  
(6) Lake Doirani; (7) Lake Agra; (8) Lake Vegoritis; (9) Lake Petron; (10), Lake Mikri 
Prespa; (11) Lake Zazari; (12) Lake Cheimaditis; (13) Lake Kastoria; (14) Aliakmon River; 
(15) Asomaton Reservoir; (16) Sfikia Reservoir; (17) Polyphyton Reservoir; (18) Lake 
Pamvotis; (19) Tavropos Reservoir; (20) Louros Reservoir; (21) Pournariou Reservoir; (22) 
Kremaston Reservoir; (23) Lake Saltini; (24) LakeVoulkaria; (25) Lake Kastrakiou; (26) 
Lake Amvrakia; (27) Lake Ozeros; (28) Lake Lysimachia; (29) Lake Trichonis; (30) Mornos 
Reservoir; (31) Lake Yliki; (32) Lake Paralimni; (33) Marathonas Reservoir; (34) Lake 
Stymfalia; (35) Pinios Reservoir; and (36) Floka Reservoir. 
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Figure 2. Box and whisker plots of the relative concentration of each microcystin  
quantified (a); the total microcystin concentration (ΣMC) in cyanobacterial bloom samples (b); 
the MC-RR to MC-LR intracellular concentration ratio (c); and the sum of MC-LR and  
MC-RR intracellular concentrations (%) to the ΣMC (d). n represents number of samples; 
U1, U5 denote the unidentified microcystin. 
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Figure 3. Relative concentration of each anabaenopeptin and/or anabaenopeptolide detected 
(a); total anabaenopeptin concentration (ΣΑ) (b); and the ratio of ΣΑ to total peptide 
concentration (ΣP) in water samples in which anabaenopeptins and/or anabaenopeptolides 
were found (c). UA1 denotes the unidentified putative anabaenopeptin. 
Table 1. Number of samples per water body surveyed in this study and frequency of MC detection. 
Number of Samples Sampling Frequency 
 1 2–10 >10 
total (n) 20 41 54 
with MC (n) 15 39 54 
frequency (%) 75 95 100 
Cluster analysis was applied to the HPLC-positive samples, using as variables the percentage of each 
peptide in the total peptide concentration. The samples formed four distinct groups (cluster tree not 
shown). Discriminant analysis of those groups (Figure 4) revealed that most of the samples follow  
a pattern in microcystin dominance (Groups 1 and 2), where MC-RR and MC-LR are always the 
predominant microcystins, followed by MC-YR or other microcystins or anabaenopeptins. In Groups 1 
and 2, the dominant species were Microcystis aeruginosa and other Microcystis spp. Two other distinct 
groups showed different patterns of microcystin predominance: for Group 3, where only MC-LR is 
predominant with percentages with respect to the ΣMC >65%; the samples were dominated by 
Microcystis aeruginosa and Anabaena (Dolichospermum) flos-aquae. Group 4 did not contain either 
MC-LR or MC-RR, and its samples were dominated by the filamentous Jaaginema subtilissimum and 
Aphanizomenon flos-aquae (Figure 4). A temporal and spatial variation in the concentrations of the 
microcystins and anabaenopeptins was observed: in Lake Mikri Prespa ΣMC was much higher in the 
1999 bloom than in the 2000, whereas the contrary was observed in Lake Pamvotis (Table S2).  
In Lake Kastoria ΣMC differed by 2–4 orders of magnitude in different sampling stations (Table S2). 
In HPLC-positive samples, ΣMC values did not differ significantly (ANOVA p > 0.1 for all pairs) 
between the three methods used (HPLC, PP1IA, ELISA). There was a high correlation in the ΣMC 
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values between all pairs of methods (data not shown). Some HPLC-negative samples had ΣMC values 
>0.5 µg·L−1 (HPLC detection limit) when measured using ELISA or PP1IA (Table S1). In those samples 
ΣMC values ranged from 1 to 20 µg·L−1 water. In HPLC-negative samples with ΣMC values between 
0.1 and 10 µg·L−1, there were no significant differences (ANOVA p > 0.1) between the values obtained 
with ELISA and PP1IA and there was a high correlation between the values (r2 = 0.759, p < 0.05). In 
HPLC-negative samples with ΣMC values <0.1 L−1, there were significant differences (ANOVA  
p < 0.05) between the values obtained with ELISA and PP1IA. The average ΣMC value obtained with 
ELISA was twice as high as the average ΣMC value obtained with PP1IA (data not shown). 
 
Figure 4. Scatter plot of the canonical scores for the two discriminant functions (Axis I and 
Axis II) of Discriminant Analysis and dominant cyanobacteria species for each group. 
Analysis of the intercorrelations between the variables: relative concentration of each 
peptide to the ΣMC. The variables are indicated by vectors. Points were plotted as two-digit 
letters, indicating freshwaters. Geometrical symbols represent the group centroids of the 
groups obtained by Cluster Analysis (not shown). Abbreviations: D: Doirani, Vo: Volvi, Ke: 
Kerkini, Μ: Mikri Prespa, Ζ: Zazari, Ka: Kastoria, P: Pamvotis, Α: Amvrakia. LR: MC-LR, 
RR: MC-RR, YR: MC-ΥR, UA1: putative anabaenopeptin UA1. 
2.3. Risk Assessment 
All samples collected from water bodies with blooms, with the exception of four samples from  
three lakes (Lakes Vistonis, Volvi, and Amvrakia), had ΣMC values that correspond to a degree of risk 
when used as recreational waters (Figure 5). 
Mar. Drugs 2015, 13 6326 
 
 
 
Figure 5. Distribution of the ΣMC values in freshwater bodies with blooms; V: Vistonis,  
D: Doirani, Vo: Volvi, Ko: Koronia, Ke: Kerkini, Μ: Mikri Prespa, Ζ: Zazari, Ka: Kastoria, 
P: Pamvotis, Α: Amvrakia. Each point represents the mean ΣMC value estimated by HPLC, 
PP1IA, and ELISA. Rectangles indicate mean ΣMC values. 
In all freshwater bodies with blooms, accidental ingestion of <2 mL of water results in doses that 
exceed the tolerable daily intake TDI (see Table 2). In Lakes Kastoria and Pamvotis, accidental ingestion 
of <80 mL of bloom-containing water would result in doses over the lowest-observed-adverse-effect 
level (LOAEL) (see Table 2). All samples collected from freshwater bodies used as drinking water had 
ΣMC values below WHO’s provisional guidelines (Figure 6). All samples collected from freshwater 
bodies without blooms had ΣMC values below 250 ng·L−1 (Figure 7), and thus no risk is posed. 
Table 2. Minimum water volume to be ingested to reach tolerable daily intake (TDI),  
no-observed-adverse-effect level (NOAEL), and lowest-observed-adverse-effect level 
(LOAEL) doses in bloom-containing water bodies of Greece. 
  Water Volume (L) 
  Vistonis Doirani Volvi Koronia Kerkini
Mikri 
Prespa
Zazari Kastoria Pamvotis Amvrakia 
TDI a 
child 0.4 0.027 0.3 0.007 0.01 0.004 0.03 3.4 × 10−5 3.0 × 10−5 3.0 × 10−4 
adult 2.2 0.16 1.8 0.04 0.09 0.02 0.18 2.1 × 10−3 1.8 × 10−3 3.0 × 10−3 
NOAEL b 
child 376.6 27.7 302.8 7.2 15.8 3.7 30.1 0.034 0.031 0.5 
adult 2259.8 166.0 1816.8 43.3 94.9 22.3 180.8 0.206 0.181 3.0 
LOAEL c 
child 941.6 69.2 757 18 39.5 9.3 75.3 0.08 0.075 1.2 
adult 5649.7 415.2 4542.1 108.3 237.3 55.8 452.1 0.516 0.45 7.5 
a 0.04 μg·MC·kg−1 bw; b 40 μg·MC·kg−1 bw; c 100 μg·MC·kg−1 bw; d 10 kg bw; e 60 kg bw; for details see Section 4.3. 
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Figure 6. Distribution of the ΣMC values in freshwater bodies without blooms used for 
drinking water; A: Aliakmon, Po: Polyphyton, K: Kremaston, Mo: Mornos, Y: Yliki,  
Pa: Paralimni, Ma: Marathonas. Each point represents the mean value of the methods 
(PP1IA, ELISA) used. Rectangles indicate mean ΣMC values. The dashed line indicates 
WHO’s provisional guideline. 
 
Figure 7. Distribution of the ΣMC values in freshwater bodies without blooms used for 
recreation or other purposes. Numbers on the x-axis indicate the freshwater number given in 
Figure 1. Each point represents the mean value and the standard deviation of the methods 
(PP1IA, ELISA) used. 
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3. Discussion 
This study demonstrates the widespread and persistent occurrence of microcystins in Greek water 
bodies, providing further information on numerous freshwater bodies not exploited before [17,19,21]. 
Microcystins were found in more than 90% of the samples and freshwater bodies investigated, 
confirming previous studies [16,17,19] that indicate that a very high percentage of the blooms in Greece 
are toxic. The likelihood of microcystin detection depends to some extent on the frequency of sampling [22]; 
microcystins in this study were found in only 75% of the waterbodies that were sampled once, but in 
95% of those sampled 2–10 times and in 100% of those sampled more than 10 times. The fact that 75% 
of the freshwaters sampled once (most of them are oligotrophic or mesotrophic [23,24] freshwater bodies 
without reported blooms) contain microcystin(s) shows that microcystin-producing strains also seem to 
occur in lakes without blooms, as previously observed [20]. In this work we sampled lakes and reservoirs 
of different size, depth, altitude typology, and trophic status [23,24]; cyanobacterial blooms dominated 
mainly by Microcystis and Anabaena (Dolichospermum) were only observed in shallow, eutrophic 
freshwater bodies [24]. 
Microcystins MC-RR, MC-LR, and MC-YR were the main toxin constituents of the Greek bloom 
samples. The presence of these three microcystins in cyanobacterial bloom samples has been described 
in southern and central Europe in countries like Portugal, France, Germany, Poland, and in other parts 
of the world including Japan and South Korea (see [16] and references therein). In Czech reservoirs the 
main variants of MCs were MC-LR, MC-RR, and MC-YR, regardless of whether the bloom was 
dominated by Microcystis or other taxa [25]. Our data show that MC-RR, MC-LR, and MC-YR 
predominance is linked to Microcystis-dominated blooms. Several studies (e.g., [26,27]) indicate that 
the genetic composition of the bloom could impact the concentrations and congeners of the microcystins 
produced. Interestingly, in Lake Pamvotis MC-RR is absent, indicating that the dominant Microcystis 
aeruginosa and Anabaena (Dolichospermum) flos-aquae produce mainly MC-LR. The unidentified MC 
U1, recognized previously in Greek samples [16], was also found to be predominant in many blooms, 
thus more research effort is needed to be identified. 
The concentrations of anabaenopeptins produced by natural populations are determined for the first 
time in this study. Despite the various biological activities (e.g., [10,28,29] that anabaenopeptins and 
related compounds exhibit, not many studies exist on their occurrence in blooms (e.g., [9,10,16,30,31]. 
In an anabaenopeptilide mutant Anabaena 90 strain, the anabaenopeptins were increased in content, 
possibly to compensate for the lack of anabaenopeptilide [32]. Repka et al. [32] suggested that 
anabaenopeptins and anabaenopeptilides, which both belong to the family of serine protease inhibitors, 
have similar functions in the cell. Furthermore, in the Anabaena 90 strain, decreased anabaenopeptin A 
and C contents were accompanied by increased anabaenopeptilide 90B contents [13]. In this study, 
anabaenopeptolide 90A was the only peptide found in one sample from Lake Mikri Prespa and the 
putative anabaenopeptin UA1 was the only peptide found in six samples in a Microcystis  
wesenbergii-dominated bloom. Similarly, in Lake Averno (Italy) anabaenopeptin B and F were found in 
the absence of microcystins [33]. Those findings support the suggestion by Tonk et al. [13] that 
cyanopeptolins, anabaenopeptins, and anabaenopeptilides are constitutively produced and thus, the 
production of cyanopeptolins, anabaenopeptins, and anabaenopeptilides resembles the constitutive 
production of microcystins. The evidence originating from the study of strains, however, are 
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contradictory: none of the Portuguese microcystin-producing Microcystis aeruginosa strains were found 
to contain microginin, microviridin, anabaenopeptin, or aeruginosinamide [13]. Anabaenopeptins and 
aeruginosinamide were also absent in genotypes that produce microcystins [8,15]. Welker et al. [9] 
reported a high percentage of microcystin and cyanopeptolin co-production. Nonetheless, the high 
(>1000 µg·L−1) anabaenopeptin concentration we found in some samples indicates that there may be 
some impact, at least on the ecology and the food web structure of the aquatic ecosystems, due to the 
presence of anabaenopeptins and related compounds. Recently, an anabaenopeptin-producing 
Microcystis flos-aquae strain was found to strongly inhibit the growth of a freshwater amoeba, indicating 
that toxic bioactive compounds other than MCs are of great importance for amoebae grazing [34]. 
The data presented show that the HPLC, ELISA, and PP1IA methods are highly correlated, especially 
at high MC concentrations. HPLC may give false-negative results in the MC concentration range of 0.5 
to 5 μg·L−1. ELISA overestimates MC concentration and may give false positive results for concentrations 
<0.1 μg·L−1. In such cases, the use of more than one method to measure MC concentrations is necessary 
(see [3,22] and references therein). The intracellular MC concentrations we found in 90% of the samples 
are similar to those reported in other countries (see [3,22]). However, the maximum intracellular MC 
values measured in Lakes Kastoria and Pamvotis, exceeding 10,000 μg·L−1, are among the highest 
reported in the literature, being lower than only two values reported from Algeria [35] and Germany [36]. 
All freshwater bodies in Greece where dense blooms occur are, by definition, above the WHO’s 
Guidance Level 3 [5] and in most of them intense recreational and other activities take place [23]. 
Recently, it was shown [18] that in Lake Pamvotis increasing water temperature and nutrient loads may act 
synergistically to promote cyanobacterial dominance and persistence. Our data confirm that heavy 
blooms producing very high microcystin concentration were already occurring in the 1990s. Thus in 
Lakes Kastoria, Pamvotis, Amvrakia, Zazari, and Vistonis, and Kerkini Reservoir, action should be 
taken in order to prevent contact with scum, possibly by prohibiting swimming and other water-contact 
activities, to initiate a public health investigation, and to inform the relevant authorities, according to 
WHO guidelines [5]. 
A key question for recreational exposure is whether cyanobacteria are sufficiently toxic to threaten 
human life. In a theoretical worst-case estimate presented by Chorus and Fastner [4], 17 mL of cyanobacterial 
cell material can be lethal for a small child. At the maximum concentrations of 10,000 and 13,200 μg·L−1 
measured in Lakes Kastoria and Pamvotis, respectively, a toxic dose for an averagely sensitive 10-kg 
toddler would require swallowing approximately 4 L of water. Repeated exposure to scum material may 
occur during a holiday at a campsite or resort located beside eutrophic water bodies, if residents  
go swimming regularly during the summer, or via sports activities. In Lakes Kastoria and Pamvotis, 
accidental ingestion of <80 mL of bloom-containing water would result in doses over the LOAEL,  
i.e., in the dose range that causes liver damage in animal studies, thus liver damage in the exposed person 
is possible. If humans are more sensitive than mice or pigs, or if a toddler is more sensitive than the 
average human being and if long-term effects are not sufficiently accounted for in the available studies, 
liver damage is even more likely [4]. Concerning freshwater bodies used for drinking water in Greece, 
the maximum concentrations were close to WHO’s guideline values [6] only in Polyphyton Reservoir 
and Lake Mornos. However, the presence of potentially toxic cyanobacteria that were not previously 
known to occur, such as Aphanizomenon ovalisporum in Lake Lysimachia [20], is an indication that 
potential problems and hazards may arise in the future through the use of the lake water. 
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4. Experimental Section 
4.1. Sample Collection 
Thirty-six lakes and reservoirs were sampled between 1996 and 2004. Geographical locations of the 
sampling sites are shown in Figure 1. Water samples (n = 104) were collected from the surface layer  
(0–35 cm) during the warm period of the year (May–October). In addition, 1 m and 2 m depth samples 
were collected from Lakes Kastoria and Pamvotis with a Nansen-type sampler. Sampling frequency 
differed between water bodies and ranged from biweekly to a single sampling. The water samples, with 
or without blooms (100–1500 mL), were kept in airtight polyethylene bottles. Bottles were placed in 
insulated boxes in the dark, transported to the laboratory, filtered through Whatman GF/C filters within 
12 h of collection, and stored at −20 °C. 
4.2. Peptide Extraction, Assays, and High-Performance Liquid Chromatography 
Whatman GF/C filters were sliced with a sterile scalpel, placed in glass tubes with 20 mL 75% (v/v) 
methanol, and sonicated (Labsonic-U; Braun, Melsungen, Germany) in an ice-bath for 15 min. The 
resulting crude extract was stirred for 1 h at room temperature, then centrifuged at 13,000× g for 10 min. 
The supernatant was collected and the pellet re-extracted twice. The three supernatants were pooled 
together, dried in an air stream, and the residue was dissolved in 1 mL Milli-Q water. Half of the volume 
of the aqueous extract was used for ELISA and Protein Phosphatase 1 inhibition assay (PP1IA). The 
other half (0.5 mL) was used to form a 1 mL 50% (v/v) methanol solution that was analyzed by  
high-performance liquid chromatography (HPLC). 
ELISA, PP1IA, and HPLC were performed according to Gkelis et al. [27]. HPLC-separated compounds 
were identified on the basis of their UV spectra and the comparison of the peak retention time with the 
retention time of the standards available or the retention time of the unidentified microcystins (U1–U4) 
and anabaenopeptin [16,20]. The qualitative standards used were MC-LR and its demethylated variants 
[D-Asp3] MC-LR, [Dha7] MC-LR, and [D-Asp3, Dha7] MC-LR; MC-RR and its demethylated variants  
[D-Asp3] MC-RR, [Dha7] MC-RR, [D-Asp3, Dha7] MC-RR, MC-LA, and MC-YR; anabaenopeptins A 
and B; and anabaenopeptilides 90A and 90B [11,37]. MC-LR and anabaenopeptin A were used as 
external standards for the quantification of MCs and anabaenopeptins/anabaenopeptilides, respectively. 
The identities of the peptides were verified by determining their molecular masses by HPLC-electron 
spray ionization mass spectrometry, using an Esquire mass spectrometer (Bruker Daltonics, Billerica 
Bremen, Germany) equipped with an ion trap interface coupled to an Agilent Technologies 1100 series 
HPLC system (for a detailed description see [38]). Quantification of unknown compounds was based on 
the assumption that fractions having the same λmax as microcystin or anabaenopeptin/anabaenopeptilide 
standards are related to microcystins or anabaenopeptins/anabaenopeptilides, respectively. 
Samples in which at least one peptide was identified and quantified by HPLC are referred to as  
HPLC-positive samples. The limit of determination and quantification was 0.3 and 0.6 μg·L−1 per peak, 
respectively, in HPLC, whereas in ELISA and PP1IA it was 0.1 and 0.15 μg·L−1, respectively. Results 
are given in ng or μg MC-LR equivalents L−1 water for ELISA and PP1A and in μg MC L−1 water for 
HPLC, respectively. The total intracellular microcystin concentration (ΣMC, µg·L−1) and the total 
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anabaenopeptin concentration (ΣA, µg·L−1) in a sample are defined as the sum of the content of the 
individual microcystins and anabaenopeptins measured in each sample, respectively. 
4.3. Risk Assessment 
The risk from the presence of MCs in lakes was assessed by comparing the total intracellular MC 
concentration (ΣMC, µg·L−1) in water samples to the thresholds established by WHO. 
According to WHO [5], in recreational waters ΣMC values in the range of 2–10 µg L−1 correspond to 
low risk, ΣMC values in the range of 10–40 µg·L−1 correspond to moderate risk, and ΣMC values  
>40 µg·L−1 correspond to high risk [39]. The amounts of water that have to be accidentally consumed in 
order to reach the tolerable daily intake (TDI; 0.04 µg·kg−1 body weight), no-observed-adverse-effect 
level (NOAEL; 40 µg·kg−1 body weight), and lowest-observed-adverse-effect level (LOAEL;  
100 µg·kg−1 body weight) thresholds [40], were estimated according to the formula: 
ܽ୵ ൌ ܮ ൈ ܾݓߑܯܥ  (1)
where: 
αw = amount of water (L) that have to be accidentally consumed in order to reach each threshold. 
L = threshold (TDI, NOAEL, LOAEL) value (µg·kg−1 body weight). 
bw = child (10 kg) or adult (60 kg) average body weight (kg). 
ΣMC = total intracellular MC concentration (µg·L−1). 
In lakes used as drinking water supplies, risk assessment was carried out by comparing the total 
intracellular MC values (ΣMC, µg·L−1) in raw water samples, using the WHO provisional guideline  
(1 µg·L−1 water).  
4.4. Statistical Analysis 
Central tendency (average, median, and confidence intervals) and variance (range, percentiles, 
standard error, and standard deviation) were used for the description of variables. Statistical analyses, 
performed with SPSS, included cluster analysis and discriminant analysis [41]. Discriminant analysis 
results were compared to dominant species occurrence data published earlier [24]. 
5. Conclusions 
This study showed the widespread and persistent occurrence of microcystins in Greek water bodies. 
The high percentage of microcystins (>90%) in the samples and freshwater bodies investigated indicates 
that blooms in Greece are toxic and that microcystin-producing strains also seem to occur in lakes 
without blooms. Anabaenopeptins and anabaenopeptolide 90A were the only peptides found in some 
samples, thus corroborating that some peptides are constitutively produced by bloom-forming 
cyanobacteria, like microcystins do. The anabaenopeptin concentration in blooms, determined for the 
first time in this study, can exceed 1000 µg·L−1, suggesting there may be some impact, at least on the 
ecology and the food web structure of the aquatic ecosystems. In freshwater bodies where heavy blooms 
occur, there is a risk posed by microcystins and action should be implemented according to World Health 
Organization guidelines. 
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